{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:37:52Z","timestamp":1792017472597,"version":"4.4.0"},"reference-count":160,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jaci.2022.12.005","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T07:04:26Z","timestamp":1675407866000},"page":"289-300.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions"],"prefix":"10.1016","volume":"151","author":[{"given":"Andrew","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea N.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Krantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir","family":"Pirmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Palubinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7623-3383","authenticated-orcid":false,"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.12.005_bib1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.13562","article-title":"EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity","volume":"74","author":"Brockow","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.12.005_bib3","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.12.005_bib4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaad.2021.04.020","article-title":"Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: facial edema aligns to the severe phenotype","volume":"85","author":"Momen","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2019.09.036","article-title":"Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: a retrospective study","volume":"82","author":"Soria","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib6","first-page":"ciac798","article-title":"A shorter time to DRESS - redefining beta-lactam associated drug reaction with eosinophilia and systemic symptoms","author":"Waldron","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2022.12.005_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2022.12.005_bib8","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/1346-8138.15490","article-title":"Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"47","author":"Torres-Navarro","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/jamadermatol.2018.5605","article-title":"Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis-ABCD-10","volume":"155","author":"Noe","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib10","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jaip.2020.07.005","article-title":"Delabeling delayed drug hypersensitivity: how far can you safely go?","volume":"8","author":"Lehloenya","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib11","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.jaip.2020.12.052","article-title":"The role of in\u00a0vivo and ex\u00a0vivo diagnostic tools in severe delayed immune-mediated adverse antibiotic drug reactions","volume":"9","author":"Copaescu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2018.10.030","article-title":"Controversies in drug allergy: testing for delayed reactions","volume":"143","author":"Phillips","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacig.2021.11.001","article-title":"Blister fluid as a cellular input for ex\u00a0vivo diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis","volume":"1","author":"Awad","year":"2022","journal-title":"J Allergy Clin Immunol Global"},{"key":"10.1016\/j.jaci.2022.12.005_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaip.2021.09.014","article-title":"Deep neural network for early image diagnosis of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"10","author":"Fujimoto","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaip.2020.08.012","article-title":"Early high-dose intravenous corticosteroids rapidly arrest Stevens Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposure","volume":"9","author":"Lehloenya","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib16","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/j.jid.2022.05.1059","article-title":"IFN-gamma ELISpot in severe cutaneous adverse reactions to first-line anti-tuberculosis drugs in an HIV endemic setting","volume":"142","author":"Porter","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/jhg.2008.5","article-title":"The HLA genomic loci map: expression, interaction, diversity and disease","volume":"54","author":"Shiina","year":"2009","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jaci.2022.12.005_bib18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cub.2005.04.050","article-title":"Pathogen-driven selection and worldwide HLA class I diversity","volume":"15","author":"Prugnolle","year":"2005","journal-title":"Curr Biol"},{"key":"10.1016\/j.jaci.2022.12.005_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fphar.2020.00078","article-title":"Genetic diversity of HLA class I and class II alleles in Thai populations: contribution to genotype-guided therapeutics","volume":"11","author":"Satapornpong","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2022.12.005_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1084\/jem.61.5.643","article-title":"Studies on the sensitization of animals with simple chemical compounds","volume":"61","author":"Landsteiner","year":"1935","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2022.12.005_bib21","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.4049\/jimmunol.1700209","article-title":"Definition of the nature and hapten threshold of the beta-lactam antigen required for T cell activation in\u00a0vitro and in patients","volume":"198","author":"Meng","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib22","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/cea.12184","article-title":"Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response","volume":"43","author":"Yun","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2022.12.005_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076211","article-title":"Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRVbeta20-1, altering pHLA recognition","volume":"8","author":"Watkins","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2022.12.005_bib24","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2022.12.005_bib25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2022.12.005_bib26","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1172\/JCI99321","article-title":"A\u00a0transgenic mouse model for HLA-B\u221757:01 linked abacavir drug tolerance and reactivity","volume":"128","author":"Cardone","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.12.005_bib27","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1172\/JCI121525","article-title":"Active suppression rather than ignorance: tolerance to abacavir-induced HLA-B\u221757:01 peptide repertoire alteration","volume":"128","author":"Phillips","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.12.005_bib28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/toxsci\/kfab084","article-title":"Deciphering adverse drug reactions: in\u00a0vitro priming and characterization of vancomycin-specific T cells from healthy donors expressing HLA-A\u221732:01","volume":"183","author":"Ogese","year":"2021","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jaci.2022.12.005_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/toxsci\/kfab144","article-title":"Checkpoint inhibition reduces the threshold for drug-specific T-cell priming and increases the incidence of sulfasalazine hypersensitivity","volume":"186","author":"Hammond","year":"2022","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jaci.2022.12.005_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","article-title":"Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response","volume":"136","author":"White","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117160","article-title":"Abacavir-reactive memory T cells are present in drug naive individuals","volume":"10","author":"Lucas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2022.12.005_bib32","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1038\/s41467-019-11396-2","article-title":"Identification of drug-specific public TCR driving severe cutaneous adverse reactions","volume":"10","author":"Pan","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2022.12.005_bib33","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archderm.1993.01680250078010","article-title":"Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement","volume":"129","author":"Correia","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib34","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jaci.2019.09.013","article-title":"Single-cell transcriptomics reveal polyclonal memory T-cell responses in skin with positive abacavir patch test results","volume":"144","author":"Redwood","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe0013","article-title":"Massive clonal expansion of polycytotoxic skin and blood CD8(+) T cells in patients with toxic epidermal necrolysis","volume":"7","author":"Villani","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jaci.2022.12.005_bib36","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jid.2019.11.020","article-title":"Analysis of skin-resident memory T cells following drug hypersensitivity reactions","volume":"140","author":"Trubiano","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41591-019-0733-7","article-title":"Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report","volume":"26","author":"Kim","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2022.12.005_bib38","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4049\/jimmunol.1602029","article-title":"The effect of inhibitory signals on the priming of drug hapten-specific T cells that express distinct Vbeta receptors","volume":"199","author":"Gibson","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib39","doi-asserted-by":"crossref","first-page":"e5749","DOI":"10.1097\/MD.0000000000005749","article-title":"Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2022.12.005_bib40","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/bcp.14433","article-title":"Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy","volume":"86","author":"Mangan","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2022.12.005_bib41","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00262-020-02699-1","article-title":"Autoimmune polyendocrine syndrome induced by immune checkpoint inhibitors: a systematic review","volume":"70","author":"Zhao","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaci.2022.12.005_bib42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.dld.2020.08.041","article-title":"Hepatitis B reactivation and immune check point inhibitors","volume":"53","author":"Godbert","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaci.2022.12.005_bib43","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00280-015-2870-0","article-title":"Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanoma","volume":"76","author":"Yamazaki","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaci.2022.12.005_bib44","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1111\/jdv.13892","article-title":"Nivolumab therapy before vemurafenib administration induces a severe skin rash","volume":"31","author":"Imafuku","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2022.12.005_bib45","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1093\/rheumatology\/key234","article-title":"High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1-associated inflammatory arthritis","volume":"57","author":"Ford","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2022.12.005_bib46","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B\u22175701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2022.12.005_bib47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B\u22175701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.12.005_bib48","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/135965350701200708","article-title":"External quality assessment of HLA-B\u22175701 reporting: an international multicentre survey","volume":"12","author":"Hammond","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jaci.2022.12.005_bib49","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jaip.2022.04.016","article-title":"Novel analysis methods to mine immune-mediated phenotypes and find genetic variation within the electronic health record (roadmap for phenotype to genotype: immunogenomics)","volume":"10","author":"Krantz","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/bioinformatics\/btz474","article-title":"arcasHLA: high-resolution HLA typing from RNAseq","volume":"36","author":"Orenbuch","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2022.12.005_bib51","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1093\/bioinformatics\/btz235","article-title":"HLA\u2217LA-HLA typing from linearly projected graph alignments","volume":"35","author":"Dilthey","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2022.12.005_bib52","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaci.2020.08.003","article-title":"Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians","volume":"147","author":"Wang","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib53","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/cpt.1915","article-title":"Genetic association of co-trimoxazole-induced severe cutaneous adverse reactions is phenotype-specific: HLA class I genotypes and haplotypes","volume":"108","author":"Sukasem","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2022.12.005_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661135","article-title":"HLA-B\u221713 :01 Is a predictive marker of dapsone-induced severe cutaneous adverse reactions in Thai patients","volume":"12","author":"Satapornpong","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib55","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1080\/14740338.2020.1796965","article-title":"The HLA-B\u221713:01 and the dapsone hypersensitivity syndrome in Korean and Asian populations: genotype- and meta-analyses","volume":"19","author":"Park","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaci.2022.12.005_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008746","article-title":"Validation study of HLA-B\u221713:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia","volume":"14","author":"Krismawati","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaci.2022.12.005_bib57","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/all.13821","article-title":"HLA-B\u221757:01 confers genetic susceptibility to carbamazepine-induced SJS\/TEN in Europeans","volume":"74","author":"Mockenhaupt","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.12.005_bib58","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A\u221732:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658593","article-title":"Characterization of T-cell responses to SMX and SMX-NO in co-trimoxazole hypersensitivity patients expressing HLA-B\u221713:01","volume":"12","author":"Pratoomwun","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib60","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaci.2020.04.056","article-title":"Cross-reactivity between vancomycin, teicoplanin and telavancin in HLA-A\u221732:01 positive vancomycin DRESS patients sharing an HLA-class II haplotype","volume":"147","author":"Nakkam","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib61","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/all.13769","article-title":"Dapsone- and nitroso dapsone-specific activation of T cells from hypersensitive patients expressing the risk allele HLA-B\u221713:01","volume":"74","author":"Zhao","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.12.005_bib62","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","article-title":"Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility","volume":"43","author":"Evans","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2022.12.005_bib63","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jhep.2019.01.034","article-title":"ERAP1 allotypes shape the epitope repertoire of virus-specific CD8(+) T cell responses in acute hepatitis C virus infection","volume":"70","author":"Kemming","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib64","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.humimm.2020.02.011","article-title":"New genetic predictors for abacavir tolerance in HLA-B\u221757:01 positive individuals","volume":"81","author":"Pavlos","year":"2020","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib65","doi-asserted-by":"crossref","unstructured":"Sun L, Wang Z, Liu T, Zhao Q, Yu G, Sun Y, et\u00a0al. TAP2 drives HLA-B\u221713:01-linked dapsone hypersensitivity syndrome tolerance and reactivity [e-pub ahead of print]. J Invest Dermatol https:\/\/doi.org\/10.1016\/j.jid.2022.10.009. Accessed November 3, 2022.","DOI":"10.1016\/j.jid.2022.10.009"},{"key":"10.1016\/j.jaci.2022.12.005_bib66","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/cpt.1944","article-title":"Global frequencies of clinically important HLA alleles and their implications for the cost-effectiveness of preemptive pharmacogenetic testing","volume":"109","author":"Zhou","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2022.12.005_bib67","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/529382","article-title":"High sensitivity of human leukocyte antigen-B\u22175701 as a marker for immunologically confirmed abacavir hypersensitivity in White and Black patients","volume":"46","author":"Saag","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2022.12.005_bib68","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2022.12.005_bib69","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A\u22173101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.12.005_bib70","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jamadermatol.2022.0484","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis-coordinating research priorities to move the field forward","volume":"158","author":"Phillips","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib71","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fphar.2019.00149","article-title":"A screening test for HLA-B\u221715:02 in a large United States patient cohort identifies broader risk of carbamazepine-induced adverse events","volume":"10","author":"Fang","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2022.12.005_bib72","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jama.2020.25473","article-title":"Race and pharmacogenomics-personalized medicine or misguided practice?","volume":"325","author":"Goodman","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2022.12.005_bib73","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2022.12.005_bib74","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt.1375","article-title":"Drug-induced liver injury due to flucloxacillin: relevance of multiple human leukocyte antigen alleles","volume":"106","author":"Nicoletti","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2022.12.005_bib75","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","article-title":"Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome","volume":"129","author":"Wei","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib76","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41397-019-0143-8","article-title":"Association of carbamazepine-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B\u221715:21 allele in Filipino patients","volume":"20","author":"Capule","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaci.2022.12.005_bib77","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ijd.15792","article-title":"HLA-B\u221715:11 status and carbamazepine-induced severe cutaneous adverse drug reactions in HLA-B\u221715:02 negative Chinese","volume":"61","author":"Wong","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib78","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/jdv.17980","article-title":"Unique motif shared by HLA-B\u221759:01 and HLA-B\u221755:02 is associated with methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese","volume":"36","author":"Jiang","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2022.12.005_bib79","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/toxsci\/kfaa124","article-title":"Identification of flucloxacillin-haptenated HLA-B\u221757:01 ligands: evidence of antigen processing and presentation","volume":"177","author":"Waddington","year":"2020","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jaci.2022.12.005_bib80","article-title":"Alterations in the HLA-B\u221757:01 immunopeptidome by flucloxacillin and immunogenicity of drug-haptenated peptides","volume":"11","author":"Puig","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib81","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/rheumatology\/kex253","article-title":"Cost effectiveness analysis of HLA-B\u221758:01 genotyping prior to initiation of allopurinol for gout","volume":"56","author":"Plumpton","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2022.12.005_bib82","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.humimm.2016.08.010","article-title":"Validation of a novel real-time PCR assay for detection of HLA-B\u221715:02 allele for prevention of carbamazepine - induced Stevens-Johnson syndrome\/toxic epidermal necrolysis in individuals of Asian ancestry","volume":"77","author":"Nguyen","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib83","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4168\/aair.2017.9.1.79","article-title":"Validation of a rapid, robust, inexpensive screening method for detecting the HLA-B\u221758:01 allele in the prevention of allopurinol-induced severe cutaneous adverse reactions","volume":"9","author":"Nguyen","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2022.12.005_bib84","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jmoldx.2019.04.006","article-title":"A Rapid allele-specific assay for HLA-A\u221732:01 to identify patients at risk for vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"21","author":"Rwandamuriye","year":"2019","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jaci.2022.12.005_bib85","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cpt.1312","article-title":"Cost-effectiveness of panel tests for multiple pharmacogenes associated with adverse drug reactions: an evaluation framework","volume":"105","author":"Plumpton","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2022.12.005_bib86","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","article-title":"SJS\/TEN 2017: building multidisciplinary networks to drive science and translation","volume":"6","author":"White","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib87","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaip.2020.09.048","article-title":"Detecting lesional granulysin levels for rapid diagnosis of cytotoxic T lymphocyte-mediated bullous skin disorders","volume":"9","author":"Chen","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib88","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI93349","article-title":"Randomized, controlled trial of TNF-\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions","volume":"128","author":"Wang","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2022.12.005_bib89","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaip.2022.01.038","article-title":"Evaluation of combination therapy with etanercept and systemic corticosteroids for Stevens-Johnson syndrome and toxic epidermal necrolysis: a multicenter observational study","volume":"10","author":"Zhang","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib90","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/bjd.19893","article-title":"Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus","volume":"185","author":"Br\u00fcggen","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib91","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw6142","article-title":"Plasma exosomal miR-375-3p regulates mitochondria-dependent keratinocyte apoptosis by targeting XIAP in severe drug-induced skin reactions","volume":"12","author":"Zhang","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2022.12.005_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2398","article-title":"Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"13","author":"Kinoshita","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2022.12.005_bib93","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaip.2018.05.037","article-title":"Differential expression of alarmins: IL-33 as a candidate marker for early diagnosis of toxic epidermal necrolysis","volume":"7","author":"Adachi","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib94","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.jaip.2019.05.002","article-title":"Galectin-7 as a potential biomarker of Stevens-Johnson syndrome\/toxic epidermal necrolysis: identification by targeted proteomics using causative drug-exposed peripheral blood cells","volume":"7","author":"Hama","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib95","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2021.03.075","article-title":"Clinical, biochemical, and serologic predictors of drug reaction with eosinophilia and systemic symptoms syndrome: a prospective case-control study","volume":"85","author":"Choudhary","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib96","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaip.2021.10.042","article-title":"Serum soluble OX40 as a diagnostic and prognostic biomarker for drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"10","author":"Mitsui","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib97","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1016\/j.jaip.2020.05.004","article-title":"HLA-A\u2217 68,-A\u2217 11: 01, and-A\u2217 29: 02 alleles are strongly associated with benznidazole-induced maculopapular exanthema (MPE)\/DRESS","volume":"8","author":"Balas","year":"2020","journal-title":"J Allergy Clini Immunol Pract"},{"key":"10.1016\/j.jaci.2022.12.005_bib98","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","article-title":"HLA-B\u2217 13: 01 and the dapsone hypersensitivity syndrome","volume":"369","author":"Zhang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.12.005_bib99","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/FPC.0000000000000306","article-title":"Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B\u221713: 01 allele in the Thai population","volume":"27","author":"Tempark","year":"2017","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaci.2022.12.005_bib100","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jid.2018.02.004","article-title":"The function of HLA-B\u221713:01 involved in the pathomechanism of dapsone-induced severe cutaneous adverse reactions","volume":"138","author":"Chen","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib101","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","article-title":"Genetic susceptibility to toxic epidermal necrolysis","volume":"123","author":"Roujeau","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib102","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jid.2019.12.025","article-title":"Association of HLA-A\u221711:01 with sulfonamide-related severe cutaneous adverse reactions in japanese patients","volume":"140","author":"Nakamura","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib103","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaci.2020.08.003","article-title":"Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians","volume":"147","author":"Wang","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib104","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A European study of HLA-B in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaci.2022.12.005_bib105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A\u221732:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib106","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1742-7843.2012.00868.x","article-title":"Association between HLA and Stevens\u2013Johnson syndrome induced by carbamazepine in southern Han Chinese: genetic markers besides B\u22171502?","volume":"111","author":"Shi","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jaci.2022.12.005_bib107","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1346-8138.2011.01457.x","article-title":"HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population","volume":"39","author":"Niihara","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib108","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/tpj.2013.40","article-title":"HLA-A\u2217 31: 01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis","volume":"14","author":"Genin","year":"2014","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaci.2022.12.005_bib109","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A\u22173101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.12.005_bib110","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","article-title":"Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans","volume":"97","author":"Kim","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jaci.2022.12.005_bib111","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/cpt.1493","article-title":"Shared genetic risk factors across carbamazepine-induced hypersensitivity reactions","volume":"106","author":"Nicoletti","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2022.12.005_bib112","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","article-title":"Relationship between the HLA-B\u22171502 allele and carbamazepine-induced stevens-johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"149","author":"Tangamornsuksan","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib113","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.57718","article-title":"Association of HLA-B\u2217 1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians","volume":"75","author":"Mehta","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaci.2022.12.005_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2780272","article-title":"Association between HLA-B alleles and carbamazepine-induced maculopapular exanthema and severe cutaneous reactions in Thai patients","volume":"2018","author":"Sukasem","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2022.12.005_bib115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"A marker for Stevens\u2013Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2022.12.005_bib116","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eplepsyres.2017.05.015","article-title":"Association between the HLA-B alleles and carbamazepine-induced SJS\/TEN: a meta-analysis","volume":"135","author":"Wang","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jaci.2022.12.005_bib117","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ijd.15792","article-title":"HLA-B\u221715:11 status and carbamazepine-induced severe cutaneous adverse drug reactions in HLA-B\u221715:02 negative Chinese","volume":"61","author":"Wong","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib118","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41397-019-0143-8","article-title":"Association of carbamazepine-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B\u221715:21 allele in Filipino patients","volume":"20","author":"Capule","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaci.2022.12.005_bib119","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/all.13821","article-title":"HLA-B\u2217 57: 01 confers genetic susceptibility to carbamazepine-induced SJS\/TEN in Europeans","volume":"74","author":"Mockenhaupt","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.12.005_bib120","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fphar.2017.00879","article-title":"Association of HLA-A and HLA-B alleles with lamotrigine-induced cutaneous adverse drug reactions in the Thai population","volume":"8","author":"Koomdee","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2022.12.005_bib121","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.anai.2017.02.011","article-title":"HLA-A\u221731:01 and lamotrigine-induced severe cutaneous adverse drug reactions in a Korean population","volume":"118","author":"Kim","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib122","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/FPC.0b013e32832c347d","article-title":"High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients","volume":"19","author":"Kazeem","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaci.2022.12.005_bib123","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/epi.12217","article-title":"HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese","volume":"54","author":"Cheung","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaci.2022.12.005_bib124","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/exd.14240","article-title":"Investigating the association of lamotrigine and phenytoin-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis with HLA-B\u22171502 in Iranian population","volume":"30","author":"Sabourirad","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.seizure.2020.05.006","article-title":"The association between HLA-A\u221703:01 and HLA-B\u221707:02 alleles and oxcarbazepine-induced maculopapular eruption in the Uighur Chinese Population","volume":"81","author":"Zhao","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.jaci.2022.12.005_bib126","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2217\/pgs.13.180","article-title":"Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects","volume":"14","author":"Kaniwa","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaci.2022.12.005_bib127","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cpt.1190","article-title":"HLA Alleles and CYP2C9\u22173 as predictors of phenytoin hypersensitivity in East Asians","volume":"105","author":"Su","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2022.12.005_bib128","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/tpj.2016.10","article-title":"Association of HLA-B\u221715:13 and HLA-B\u221715:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population","volume":"17","author":"Chang","year":"2017","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaci.2022.12.005_bib129","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B\u2217 1502 allele in Thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaci.2022.12.005_bib130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FPC.0000000000000211","article-title":"Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population","volume":"26","author":"Tassaneeyakul","year":"2016","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaci.2022.12.005_bib131","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/bcp.14025","article-title":"High and variable population prevalence of HLA-B\u2217 56: 02 in indigenous Australians and relation to phenytoin-associated drug reaction with eosinophilia and systemic symptoms","volume":"85","author":"Somogyi","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2022.12.005_bib132","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/pgs.09.162","article-title":"Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese","volume":"11","author":"Hung","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaci.2022.12.005_bib133","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/529382","article-title":"High sensitivity of human leukocyte antigen-b\u2217 5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients","volume":"46","author":"Saag","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2022.12.005_bib134","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B\u2217 5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2022.12.005_bib135","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B\u2217 5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.12.005_bib136","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaci.2015.03.019","article-title":"Pharmacogenetics of abacavir hypersensitivity: a systematic review and meta-analysis of the association with HLA-B\u221757:01","volume":"136","author":"Sousa-Pinto","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.12.005_bib137","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1089\/aid.2011.0107","article-title":"HLA-dependent hypersensitivity reaction to nevirapine in Chinese Han HIV-infected patients","volume":"28","author":"Gao","year":"2012","journal-title":"AIDS Res Hum Retrovirus"},{"key":"10.1016\/j.jaci.2022.12.005_bib138","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/cid\/cit021","article-title":"Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population","volume":"56","author":"Carr","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2022.12.005_bib139","first-page":"1152","article-title":"Genome-wide association study of nevirapine hypersensitivity in a Sub-Saharan African HIV-infected population","volume":"72","author":"Carr","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaci.2022.12.005_bib140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/QAD.0b013e32801199d9","article-title":"HLA-Cw8 primarily associated with hypersensitivity to nevirapine","volume":"21","author":"Gatanaga","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jaci.2022.12.005_bib141","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/01.aids.0000238408.82947.09","article-title":"HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients","volume":"20","author":"Littera","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jaci.2022.12.005_bib142","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/FPC.0b013e32831d0faf","article-title":"HLA-B\u2217 3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients","volume":"19","author":"Chantarangsu","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaci.2022.12.005_bib143","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00002030-200501030-00014","article-title":"Predisposition to nevirapine hypersensitivity associated with HLA-DRB1\u22170101 and abrogated by low CD4 T-cell counts","volume":"19","author":"Martin","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jaci.2022.12.005_bib144","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/cid\/cix096","article-title":"Association of the HLA-B\u221753:01 allele with drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome during treatment of HIV infection with raltegravir","volume":"64","author":"Thomas","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2022.12.005_bib145","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1346-8138.2010.00921.x","article-title":"Stevens\u2013Johnson syndrome induced by acetazolamide","volume":"38","author":"Her","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib146","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2217\/pgs.15.21","article-title":"Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review","volume":"16","author":"Jarjour","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaci.2022.12.005_bib147","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjd.12389","article-title":"HLA-B\u221758:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome\/toxic epidermal necrolysis in a Portuguese population","volume":"169","author":"Gon\u00e7alo","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib148","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2133.2012.10894.x","article-title":"Association between HLA-B58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong","volume":"167","author":"Chiu","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2022.12.005_bib149","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/FPC.0b013e32834282b8","article-title":"Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans","volume":"21","author":"Kang","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaci.2022.12.005_bib150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fphar.2016.00186","article-title":"HLA-B (\u2217) 58:01 for allopurinol-induced cutaneous adverse drug reactions: implication for clinical interpretation in Thailand","volume":"7","author":"Sukasem","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2022.12.005_bib151","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2217\/pgs-2021-0156","article-title":"Allopurinol-induced severe cutaneous adverse reactions in Vietnamese: the role of HLA alleles and other risk factors","volume":"23","author":"Ha Pham","year":"2022","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaci.2022.12.005_bib152","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","article-title":"HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Kaniwa","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaci.2022.12.005_bib153","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/1756-185X.13143","article-title":"Diagnostic utility of HLA-B\u2217 5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis","volume":"20","author":"Yu","year":"2017","journal-title":"International journal of rheumatic diseases"},{"key":"10.1016\/j.jaci.2022.12.005_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-52619-2","article-title":"Identification of HLA-A\u2217 0 2: 06: 01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing","volume":"9","author":"Nakatani","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2022.12.005_bib155","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41397-018-0052-2","article-title":"Association between HLA-B\u22175901 and methazolamide-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"19","author":"Tangamornsuksan","year":"2019","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaci.2022.12.005_bib156","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/tpj.2015.25","article-title":"HLA-B\u221759:01: a marker for Stevens-Johnson syndrome\/toxic epidermal necrolysis caused by methazolamide in Han Chinese","volume":"16","author":"Yang","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaci.2022.12.005_bib157","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/jdv.17980","article-title":"Unique motif shared by HLA-B\u221759:01 and HLA-B\u221755:02 is associated with methazolamide-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese","volume":"36","author":"Jiang","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2022.12.005_bib158","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1007\/s00198-016-3568-9","article-title":"Increased risk of strontium ranelate-related SJS\/TEN is associated with HLA","volume":"27","author":"Lee","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jaci.2022.12.005_bib159","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2217\/pgs.14.69","article-title":"HLA-B\u221713:01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemic symptoms in Chinese Han population","volume":"15","author":"Yang","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaci.2022.12.005_bib160","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2021-220578","article-title":"Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1\u221715 alleles","volume":"81","author":"Saper","year":"2022","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922016591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922016591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:41:21Z","timestamp":1758793281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922016591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":160,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0091674922016591"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.12.005","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}